Mice fed with a high-fat diet showed increased IL-17-mediated skin inflammation by imiquimod treatment and enhancement of the production of IL-17 producing cells even in the steady state [60], suggesting that the IL-17-dominant baseline condition is involved in the mechanism of obesity-related Th17 cutaneous inflammation. The gene discussed is IL17A; the disease is obesity disorder.